Precision Optics Corporation Reports Fiscal Year 2024 Results

Precision Optics Corporation (Ticker: POCI), a leader in advanced optical technology, reported a revenue of $19.1 million for the fiscal year 2024, surpassing its pre-announced expectations despite operational challenges.

The company’s CEO, Dr. Joe Forkey, announced during the Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call on August 14, 2024, that while there were revenue losses, optimism remains about future growth, especially in the single-use medical devices market and a new platform product.

Key Takeaways

• Revenue of $19.1 million surpassed the expected range of $18.5 million to $18.9 million.
• Experienced a $5.6 million revenue loss from discontinued programs and a $1.5 million decline in the Ross Optical division.
• Achieved a record production order of $9 million in May and a 24% year-over-year growth in product development revenue.
• Anticipates a strong start to Fiscal Year 2025 with increased revenue in Q2 following a temporary dip in Q1.
• Developing a new platform product focused on customer development alongside expanding the engineering team.

Company Outlook

• Q1 revenue for Fiscal Year 2025 is projected between $4.2 million and $4.4 million.
• The $9 million production order is expected to add $3.6 million in revenue for fiscal 2025.
• Planning to participate in the Lytham Partners Fall 2024 Investor Conference on October 10, 2024.

Bearish Highlights

• Gross margins decreased to 30% from 38% in the previous year; Q4 margins were 22%.
• Net loss for fiscal 2024 was reported at $3 million.

Bullish Highlights

• The medical device market forecasts a 5% to 10% growth, with single-use products expected to outpace this growth.
• Anticipating record revenues in Q2 of Fiscal Year 2025 and beyond.
• Defense/aerospace margins exceeded 50%, indicating strong potential in this sector.

Misses

• Fiscal 2024 revenue was slightly lower than projections due to discontinued programs and industry slowdowns.

Q&A Highlights

• The company is using intellectual property to enhance product offerings, aiming to accelerate time to market while maintaining customizability.

Precision Optics has shown resilience amidst challenges and is positioned for growth in the upcoming fiscal year, focusing on the medical device sector and intellectual property strategies. InvestingPro Insights reflects the company’s market capitalization at $35.43 million and highlights performance-related challenges. Despite a 6.73% revenue decline over the last year, moderate debt levels provide financial flexibility for growth.

Full Transcript – Precision Optics Corporation Inc (POCI) Q4 2024:

Operator: Good afternoon and welcome to the Precision Optics Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call…
Robert Blum: Thank you, Gary, and everyone joining the call today…
Wayne Coll: Thank you, Joe. Let me expand on some of Joe’s comments on the financial results…
Joe Forkey: […] fiscal 2024 was certainly a challenging year. We will see a sharp increase in revenue in Q2 with record quarterly revenues before the end of fiscal 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.